Drug Database
N-

N-1037

✓ Approved

Bausch Health Companies Inc. · 小分子 · 小分子

什么是 N-1037?

N-1037 是一种小分子,由Bausch Health Companies Inc.研发。该药已获批,用于治疗相关适应症,给药途径:Others、Inhaled、Topical。

药物档案

公司Bausch Health Companies Inc.
药物类别小分子
给药途径Others, Inhaled, Topical
状态Approved

治疗适应症

N-1037 针对 2 个适应症,涉及 2 个治疗领域。

治疗领域疾病/病症分期
Eye disordersConjunctivitis allergic✓ Approved
Respiratory, thoracic and mediastinal disordersRhinitis allergic✓ Approved

相关研究文献

PubMedOrthodontics & craniofacial research2026-11-19

Predicting Orthognathic Surgery in Cleft Patients: A Cephalometric Study.

Koskela Hanna H, Podleśny Mateusz H MH, Lithovius Riitta R, Ylikontiola Leena L et al.

The aim of this study was to determine whether certain cephalometric findings can predict the future need for orthognathic surgery (OS) in cleft lip (CL), cleft palate (CP), unilateral cleft lip and palate (UCLP), bilateral cleft lip and palate (BCLP), cleft lip and alveolus (CLA) and submucous cleft palate (SMCP) at different stages of growth. This retrospective longitudinal study involved 154 cleft patients. The study group consisted of CP (n = 93), SMCP (n = 22), UCLP (n = 19), BCLP (n = 8), CL (n = 7) and CLA (n = 5) patients born between 1989 and 2006 who were treated at Oulu Cleft Center (OCC). Lateral cephalograms were analysed at the age of 6, 10, 16 and 18. The need for OS was determined from hospital records. Wits appraisal (< 0.001) and ANB (p < 0,001) values predicted the later need for OS at different stages of growth from 10 years onwards. This study found that Wits appraisal and ANB angle can predict the need for OS in the future in cleft patients.

PMID 43053605
阅读全文 →
PubMedNPJ vaccines2026-11-19

Chitosan-based nanoparticles encapsulating Nocardia seriolae lysates confer protection against nocardiasis through immersion vaccination in Micropterus salmoides.

Li Lijuan L, Liu Zhimin Z, Sun Yihan Y, Li Kesong K et al.

Development of effective vaccines with convenient administration, including oral immunization or immersion, to control pathogens is important for the sustainability of aquaculture. Nocardia seriolae was found to harm over 40 types of cultured marine and freshwater species, especially in Micropterus salmoides and Channa argus, causing more than 30% mortality. In this study, a novel isolate of N. seriolae (B20200724) growing fast and manifesting comparative virulence with other N. seriolae was identified from diseased M. salmoides. Chitosan-based nanoparticles encapsulating whole-cell lysates of N. seriolae B20200724 with great mucoadhesive features were prepared for evaluation of the protective effect against N. seriolae in M. salmoides. Chitosan-based nanoparticles via immersion vaccination boost the innate immune response, elicit the expression of Th2 cytokines and high-titer antibody responses, ultimately conferring a 45% relative protection rate against N. seriolae infection. These findings provide a novel vaccine candidate and verify a convenient immunization route, which promotes the potential of the vaccine against fish nocardiosis for commercial use.

PMID 43052343
阅读全文 →
PubMedEcological applications : a publication of the Ecological Society of America2026-11-19

Decadal trade-offs between productivity and climate resilience in intensified native grasslands.

Caram Nicolas N, Casalás Felipe F, García-Favre Javier J, Zanoniani Ramiro R et al.

Grasslands cover approximately 40% of the global terrestrial area and support essential ecosystem services; however, productivity is commonly constrained by overgrazing and nitrogen (N) availability. Productivity can be boosted through improved grazing management and increased N supply, either indirectly via overseeding N-fixing legumes or directly through mineral N fertilization. Yet, how productivity gains from contrasting intensification pathways trade-off with resilience to climate variability remains underexplored. In a decade-long field experiment in Campos grassland that captured wide interannual rainfall variability, we evaluated seasonal and annual aboveground net primary production (ANPP), net secondary production (NSP), temporal stability (μ/σ), and trophic efficiency (NSP:ANPP) within a Bayesian hierarchical framework that jointly modeled mean production and its interannual variability. Responses were assessed across four management strategies under similar grazing management but differing in intensification level: native grassland (NG) without external inputs, legume-overseeded grassland with phosphorus (P) fertilization, and NGs fertilized with P and either 60 or 120 kg N ha-1 y-1. Intensification boosted annual ANPP from 5.6 Mg DM ha-1 (95% CI: 4.6-6.8) in NG to 6.2 Mg DM ha-1 (5.0-7.6) in the legume-overseeded grassland (+11%) and to 7.4 Mg DM ha-1 (6.1-8.8) under N fertilization (+32%). Responses saturated across N rates and differences were primarily driven by higher winter and spring ANPP. Associated with improved trophic efficiency, intensification determined disproportionate increases in annual NSP relative to ANPP: NG averaged 198 kg LW ha-1 (123-272), legume overseeded achieved 306 kg LW ha-1 (217-394; +54%), and N fertilized reached 416 kg LW ha-1 (300-529; +110%). Remarkably, intensification did not reduce temporal stability, as increases in production were accompanied by proportional increases in interannual variability. Nonetheless, intensification progressively increased the rainfall dependence of NSP, particularly during summer (R2 = 0.86). NSP shifted from negative to positive values at approximately 350 mm of summer rainfall (≈50% of summers since 1982) in N-fertilized grasslands, but at only approximately 200 mm (≈80% of summers) in native and legume-overseeded grasslands. Rather than revealing simple productivity-resilience trade-offs, these rainfall-dependent thresholds highlight the need to balance productivity gains against climatic risk probabilistically, providing actionable insights for climate-resilient grassland systems in the Anthropocene.

PMID 43053618
阅读全文 →
PubMedHaematologica2026-11-19

Severe and fatal central nervous system toxicity after fludarabine, thiotepa and melphalan conditioning for allogeneic stem cell transplantation.

Schonewille Pleun P, Kottink Bram B, Berendsen Sharon S, Van der Leest Yousra Y et al.

Neurological complications (NC) are a known risk after allogeneic hematopoietic stem cell transplantation (allo-HSCT). In routine clinical care, we observed unexpected severe noninfectious central nervous system (CNS) events following conditioning with fludarabine, thiotepa and melphalan (Flu-Thio-Mel). To assess the potential association between NC and Flu-Thio-Mel conditioning, we conducted a systematic retrospective evaluation of the frequency, type, location and etiology of NC in adult patients who received αβTCR+/CD19+-depleted allo-HSCT. Only NC considered conditioningrelated, based on clinical and diagnostic findings, were included. Outcomes were compared between patients receiving Flu-Thio-Mel (N=55) and patients receiving fludarabine and busulfan (Flu-Bu; N=47) as conditioning regimen for allo-HSCT. Overall, NC were frequent in both cohorts (31% after Flu-Thio-Mel and 30% after Flu-Bu) and most often clinically mild. Peripheral neuropathy was the most common manifestation. In contrast, CNS toxicity was observed exclusively in the Flu-Thio-Mel cohort (n=7), presenting as fatal leukoencephalopathy (n=3, CTCAE grade 5), severe encephalomyelopathy (n=2, CTCAE grade 3-4), and myeloneuropathy (n=2, CTCAE grade 2). Older age, impaired renal function and higher fludarabine exposure may have increased susceptibility to Flu-Thio-Mel-associated CNS toxicity. The occurrence of severe CNS toxicity (CTCAE grade 3-5) in 9% of patients after Flu-Thio-Mel warrants caution and further evaluation of this conditioning regimen, particularly in vulnerable patients.

PMID 43053705
阅读全文 →
PubMedBMC neurology2026-11-19

Inflammatory diseases of the central nervous system in adults at the Brazzaville University Hospital Center, Congo.

Diatewa J E JE, Sounga-Bandzouzi E P EP, Motoula-Latou D A Boubayi DAB, Mpandzou G A GA et al.

Inflammatory diseases (IDs) of the central nervous system (CNS) constitute a heterogeneous group of immune-mediated disorders that can lead to neurological disability. Data on these diseases remain limited in sub-Saharan Africa. To describe the epidemiological, clinical, and paraclinical aspects of CNS IDs in adults in Brazzaville, Congo; to describe the therapeutic strategies implemented; to evaluate the outcome of pathological entities at hospital discharge. This was a retrospective descriptive study carried out in the neurology department of the Brazzaville University Hospital Center. The study period was from January 2018 to December 2023. The study included patients aged 18 years or older. The diagnosis of each entity of CNS IDs was based on clinical data, MRI findings, cerebrospinal fluid analysis, and available laboratory investigations, according to international consensus criteria for this disease. At hospital discharge, the documented clinical outcome was as follows: improvement, stabilization, or deterioration. Of the 44 patients included in the study, 29 (65.9%) were women. The average age of the patients was 35.0 ± 9.9 years. The most common diagnostic categories were idiopathic acute transverse myelitis (n = 10), unclassified acute inflammatory medullary syndrome (n = 10), neuromyelitis optica spectrum disorders (n = 5), and isolated optic neuritis (n = 5). Intravenous corticosteroid therapy with methylprednisolone was administered to all patients, followed by oral prednisolone. Maintenance immunosuppressive therapy was initiated in 5 (11.4%) patients. At hospital discharge, three types of outcomes for CNS IDs were recorded: clinical improvement (n = 29; 65.9%); stabilization (n = 10; 22.7%), and deterioration (n = 5; 11.4%). The spectrum of CNS IDs in adults in Brazzaville is broad. In our cohort, IDs of the CNS are predominantly characterized by spinal cord syndromes. The lack of specific biomarkers has limited the accuracy of the diagnosis. Overall, the immunosuppressive therapy used has led to a clinical improvement in most patients at hospital discharge.

PMID 43052790
阅读全文 →
PubMedEuropean heart journal. Valvular and structural heart disease2026-11-19

Surgical care for rheumatic heart disease patients: insights from the Netherlands Heart Registration.

de Wilde Lotte L G LLG, El Mathari Sulayman S, Blokhuis Diederik W M DWM, Roefs Maaike M MM et al.

Although rheumatic heart disease (RHD) has declined in high-income countries, migration sustains its presence. Definite therapy for RHD is surgical mitral valve replacement (MVR), but data are lacking in the Netherlands. This study evaluated the overall surgical care for RHD patients with data from the Netherlands Heart Registration (NHR). This prospective cohort study included RHD MVR patients from all cardiothoracic centres (n = 16) in the Netherlands. RHD MVR patients aged ≤75 years were identified in the NHR database between 2017 and 2023. Baseline, admission, procedural, and outcome data were analysed, with up to 5 years of follow-up. RHD patients were compared across centre volumes, divided into tertiles, and with non-RHD MVR patients in the NHR database. Overall, 435 RHD patients were included with a mean (SD) age of 58 (12) years, and 73.3% (n = 319) was female. Upon admission, 77.0% (n = 335) of patients had a LVEF ≥50.0%, 40.2% (n = 175) had atrial fibrillation, and 45.3% (n = 197) were highly symptomatic (NYHA III-IV). Within a median (IQR) post-operative follow-up of 2.9 (1.1-4.6) years, total uncensored mortality was 12.2% (n = 53). One-year mortality was similar among RHD MVR patients in high-volume (>200 MVRs) (6.9%) and low-volume (<132 MVRs) (7.6%) centres (P = .791). One-year mortality did not differ between RHD (6.4%) and non-RHD (13.8%) MVR patients (HR: 0.80; 95% CI 0.53-1.21; P = .288). These data show effective surgical care for RHD MVR patients, with similar 1-year mortality rates across centre volumes and compared with non-RHD MVR patients, suggesting that RHD MVR patients can be managed similarly as non-RHD MVR patients.

PMID 43053856
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多N-1037